LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 50.33 | 17.25 | 43 | 4651 | 0.0092 | 0.1198 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 50.33 | 17.25 | 3286 | 4651 | 0.7065 | 0.9158 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 50.33 | 17.25 | 3333 | 4651 | 0.7166 | 0.9191 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 50.33 | 17.25 | 3579 | 4651 | 0.7695 | 0.9361 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 52.30 | 17.25 | 29 | 4798 | 0.0060 | 0.0661 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 52.30 | 17.25 | 3476 | 4798 | 0.7244 | 0.9221 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 52.30 | 17.25 | 2980 | 4798 | 0.6210 | 0.8860 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 52.30 | 17.25 | 3767 | 4798 | 0.7850 | 0.9413 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.27 | 17.25 | 33 | 4884 | 0.0068 | 0.0829 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.27 | 17.25 | 3674 | 4884 | 0.7522 | 0.9313 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.27 | 17.25 | 3678 | 4884 | 0.7531 | 0.9316 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 54.27 | 17.25 | 4069 | 4884 | 0.8331 | 0.9557 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.24 | 17.25 | 29 | 4929 | 0.0059 | 0.0657 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.24 | 17.25 | 3868 | 4929 | 0.7847 | 0.9415 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.24 | 17.25 | 3322 | 4929 | 0.6740 | 0.9056 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 56.24 | 17.25 | 4244 | 4929 | 0.8610 | 0.9637 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 17.25 | 27 | 4942 | 0.0055 | 0.0564 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 17.25 | 4096 | 4942 | 0.8287 | 0.9545 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 17.25 | 3379 | 4942 | 0.6837 | 0.9090 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 17.25 | 4481 | 4942 | 0.9066 | 0.9761 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.18 | 17.25 | 34 | 5031 | 0.0068 | 0.0864 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.18 | 17.25 | 4354 | 5031 | 0.8654 | 0.9650 | MN20160310_N02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.18 | 17.25 | 3581 | 5031 | 0.7117 | 0.9186 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.18 | 17.25 | 4669 | 5031 | 0.9280 | 0.9818 | MN20160310_N02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 63.15 | 17.25 | 39 | 5061 | 0.0077 | 0.1046 | MN20160310_N02 | K22 |